Cargando…

Pulmonary embolism in chronic kidney disease and end-stage renal disease hospitalizations: Trends, outcomes, and predictors of mortality in the United States

BACKGROUND: It is well-known that patients with chronic kidney disease and end-stage renal disease are at increased risk of pulmonary embolism than patients with normal kidney function. However, the data on trends, outcomes, and predictors of mortality in pulmonary embolism patients with chronic kid...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Jagmeet, Khadka, Sushmita, Solanki, Dhanshree, Kichloo, Asim, Shah, Harshil, Vyas, Manasee J, Chugh, Savneek, Patel, Neil, Solanki, Shantanu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182212/
https://www.ncbi.nlm.nih.gov/pubmed/34158942
http://dx.doi.org/10.1177/20503121211022996
_version_ 1783704160732971008
author Singh, Jagmeet
Khadka, Sushmita
Solanki, Dhanshree
Kichloo, Asim
Shah, Harshil
Vyas, Manasee J
Chugh, Savneek
Patel, Neil
Solanki, Shantanu
author_facet Singh, Jagmeet
Khadka, Sushmita
Solanki, Dhanshree
Kichloo, Asim
Shah, Harshil
Vyas, Manasee J
Chugh, Savneek
Patel, Neil
Solanki, Shantanu
author_sort Singh, Jagmeet
collection PubMed
description BACKGROUND: It is well-known that patients with chronic kidney disease and end-stage renal disease are at increased risk of pulmonary embolism than patients with normal kidney function. However, the data on trends, outcomes, and predictors of mortality in pulmonary embolism patients with chronic kidney disease and end-stage renal disease in the United States are limited. METHODS: We queried the National Inpatient Sample database from 2010 to 2014. International Classification of Diseases-Ninth Revision-Clinical Modification codes were used to identify patients with normal kidney function, chronic kidney disease, and end-stage renal disease. The frequency of pulmonary embolism, complications, in-hospital mortality, and length of stay were calculated for each cohort. Multivariable logistic regression models were constructed to determine the predictors of mortality. RESULTS: In the study population (2010–2014), there were 766,176 pulmonary embolism hospitalizations with normal kidney function, 79,824 with chronic kidney disease, and 9147 with end-stage renal disease. Among the study cohorts, the mortality rate was 2.7% in normal kidney function, 4.5% in chronic kidney disease, and 6.8% in end-stage renal disease hospitalizations. Median length of stay was highest in the end-stage renal disease cohort and lowest in the normal kidney function cohort. After adjusting for confounders, pulmonary embolism patients with chronic kidney disease died 1.15 times more often than those with normal kidney function and pulmonary embolism patients with end-stage renal disease died 4.2 times more often than those with normal kidney function. CONCLUSION: The mortality rate and length of stay in pulmonary embolism patients with chronic kidney disease and end-stage renal disease were significantly higher than those in pulmonary embolism patients with normal kidney function. Also, pulmonary embolism patients with chronic kidney disease and end-stage renal disease were at higher risk of in-hospital mortality than those with normal kidney function. There was statistically significant higher risk of mortality in elderly and Black patients with pulmonary embolism and concurrent chronic kidney disease or end-stage renal disease.
format Online
Article
Text
id pubmed-8182212
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-81822122021-06-21 Pulmonary embolism in chronic kidney disease and end-stage renal disease hospitalizations: Trends, outcomes, and predictors of mortality in the United States Singh, Jagmeet Khadka, Sushmita Solanki, Dhanshree Kichloo, Asim Shah, Harshil Vyas, Manasee J Chugh, Savneek Patel, Neil Solanki, Shantanu SAGE Open Med Original Research Article BACKGROUND: It is well-known that patients with chronic kidney disease and end-stage renal disease are at increased risk of pulmonary embolism than patients with normal kidney function. However, the data on trends, outcomes, and predictors of mortality in pulmonary embolism patients with chronic kidney disease and end-stage renal disease in the United States are limited. METHODS: We queried the National Inpatient Sample database from 2010 to 2014. International Classification of Diseases-Ninth Revision-Clinical Modification codes were used to identify patients with normal kidney function, chronic kidney disease, and end-stage renal disease. The frequency of pulmonary embolism, complications, in-hospital mortality, and length of stay were calculated for each cohort. Multivariable logistic regression models were constructed to determine the predictors of mortality. RESULTS: In the study population (2010–2014), there were 766,176 pulmonary embolism hospitalizations with normal kidney function, 79,824 with chronic kidney disease, and 9147 with end-stage renal disease. Among the study cohorts, the mortality rate was 2.7% in normal kidney function, 4.5% in chronic kidney disease, and 6.8% in end-stage renal disease hospitalizations. Median length of stay was highest in the end-stage renal disease cohort and lowest in the normal kidney function cohort. After adjusting for confounders, pulmonary embolism patients with chronic kidney disease died 1.15 times more often than those with normal kidney function and pulmonary embolism patients with end-stage renal disease died 4.2 times more often than those with normal kidney function. CONCLUSION: The mortality rate and length of stay in pulmonary embolism patients with chronic kidney disease and end-stage renal disease were significantly higher than those in pulmonary embolism patients with normal kidney function. Also, pulmonary embolism patients with chronic kidney disease and end-stage renal disease were at higher risk of in-hospital mortality than those with normal kidney function. There was statistically significant higher risk of mortality in elderly and Black patients with pulmonary embolism and concurrent chronic kidney disease or end-stage renal disease. SAGE Publications 2021-06-03 /pmc/articles/PMC8182212/ /pubmed/34158942 http://dx.doi.org/10.1177/20503121211022996 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research Article
Singh, Jagmeet
Khadka, Sushmita
Solanki, Dhanshree
Kichloo, Asim
Shah, Harshil
Vyas, Manasee J
Chugh, Savneek
Patel, Neil
Solanki, Shantanu
Pulmonary embolism in chronic kidney disease and end-stage renal disease hospitalizations: Trends, outcomes, and predictors of mortality in the United States
title Pulmonary embolism in chronic kidney disease and end-stage renal disease hospitalizations: Trends, outcomes, and predictors of mortality in the United States
title_full Pulmonary embolism in chronic kidney disease and end-stage renal disease hospitalizations: Trends, outcomes, and predictors of mortality in the United States
title_fullStr Pulmonary embolism in chronic kidney disease and end-stage renal disease hospitalizations: Trends, outcomes, and predictors of mortality in the United States
title_full_unstemmed Pulmonary embolism in chronic kidney disease and end-stage renal disease hospitalizations: Trends, outcomes, and predictors of mortality in the United States
title_short Pulmonary embolism in chronic kidney disease and end-stage renal disease hospitalizations: Trends, outcomes, and predictors of mortality in the United States
title_sort pulmonary embolism in chronic kidney disease and end-stage renal disease hospitalizations: trends, outcomes, and predictors of mortality in the united states
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182212/
https://www.ncbi.nlm.nih.gov/pubmed/34158942
http://dx.doi.org/10.1177/20503121211022996
work_keys_str_mv AT singhjagmeet pulmonaryembolisminchronickidneydiseaseandendstagerenaldiseasehospitalizationstrendsoutcomesandpredictorsofmortalityintheunitedstates
AT khadkasushmita pulmonaryembolisminchronickidneydiseaseandendstagerenaldiseasehospitalizationstrendsoutcomesandpredictorsofmortalityintheunitedstates
AT solankidhanshree pulmonaryembolisminchronickidneydiseaseandendstagerenaldiseasehospitalizationstrendsoutcomesandpredictorsofmortalityintheunitedstates
AT kichlooasim pulmonaryembolisminchronickidneydiseaseandendstagerenaldiseasehospitalizationstrendsoutcomesandpredictorsofmortalityintheunitedstates
AT shahharshil pulmonaryembolisminchronickidneydiseaseandendstagerenaldiseasehospitalizationstrendsoutcomesandpredictorsofmortalityintheunitedstates
AT vyasmanaseej pulmonaryembolisminchronickidneydiseaseandendstagerenaldiseasehospitalizationstrendsoutcomesandpredictorsofmortalityintheunitedstates
AT chughsavneek pulmonaryembolisminchronickidneydiseaseandendstagerenaldiseasehospitalizationstrendsoutcomesandpredictorsofmortalityintheunitedstates
AT patelneil pulmonaryembolisminchronickidneydiseaseandendstagerenaldiseasehospitalizationstrendsoutcomesandpredictorsofmortalityintheunitedstates
AT solankishantanu pulmonaryembolisminchronickidneydiseaseandendstagerenaldiseasehospitalizationstrendsoutcomesandpredictorsofmortalityintheunitedstates